168 related articles for article (PubMed ID: 23718873)
1. HPV status and second primary tumours in oropharyngeal squamous cell carcinoma.
Xu CC; Biron VL; Puttagunta L; Seikaly H
J Otolaryngol Head Neck Surg; 2013 May; 42(1):36. PubMed ID: 23718873
[TBL] [Abstract][Full Text] [Related]
2. A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas.
Wang F; Zhang H; Xue Y; Wen J; Zhou J; Yang X; Wei J
Cancer Med; 2017 May; 6(5):910-917. PubMed ID: 28378539
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 5 and 7 expression may impact prognosis of HPV-positive oropharyngeal squamous cell carcinoma patients.
Jouhi L; Mohamed H; Mäkitie A; Remes SM; Haglund C; Atula T; Hagström J
Cancer Immunol Immunother; 2017 Dec; 66(12):1619-1629. PubMed ID: 28856441
[TBL] [Abstract][Full Text] [Related]
4. Oral health and human papillomavirus-associated head and neck squamous cell carcinoma.
Mazul AL; Taylor JM; Divaris K; Weissler MC; Brennan P; Anantharaman D; Abedi-Ardekani B; Olshan AF; Zevallos JP
Cancer; 2017 Jan; 123(1):71-80. PubMed ID: 27571516
[TBL] [Abstract][Full Text] [Related]
5. The Incidence, Survival, and HPV Impact of Second Primary Cancer following Primary Oropharyngeal Squamous Cell Carcinoma: A 20-Year Retrospective and Population-Based Study.
Andersen L; Jakobsen KK; Carlander AF; Garset-Zamani M; Friborg J; Kiss K; Marvig RL; Olsen C; Nielsen FC; Andersen E; Grønhøj C; Buchwald CV
Viruses; 2022 Dec; 15(1):. PubMed ID: 36680074
[TBL] [Abstract][Full Text] [Related]
6. HPV testing versus p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: results from the DAHANCA 19 study.
Lilja-Fischer JK; Kristensen MH; Lassen P; Steiniche T; Tramm T; Stougaard M; Maare C; Johansen J; Primdahl H; Kristensen CA; Andersen M; Eriksen JG; Overgaard J
Acta Oncol; 2023 Nov; 62(11):1384-1388. PubMed ID: 37837201
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus (HPV) load is higher in HPVDNA/p16 positive than in HPVDNA positive/p16 negative oropharyngeal squamous cell carcinoma but does not differ significantly between various subsites or correlate to survival.
Zupancic M; Kostopoulou ON; Holzhauser S; Lukoseviciute M; Jylhä C; Marklund L; Näsman A; Sivars L; Dalianis T
Oral Oncol; 2024 Apr; 151():106749. PubMed ID: 38461771
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of oropharyngeal squamous cell carcinoma stratified by human papillomavirus subtype: A systematic review and meta-analysis.
Shenker RF; Razavian NB; D'Agostino RB; Mowery YM; Brizel DM; Hughes RT
Oral Oncol; 2024 Jan; 148():106644. PubMed ID: 38006690
[TBL] [Abstract][Full Text] [Related]
9. Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents.
D'Souza G; Anantharaman D; Gheit T; Abedi-Ardekani B; Beachler DC; Conway DI; Olshan AF; Wunsch-Filho V; Toporcov TN; Ahrens W; Wisniewski K; Merletti F; Boccia S; Tajara EH; Zevallos JP; Levi JE; Weissler MC; Wright S; Scelo G; Mazul AL; Tommasino M; Cadoni G; Brennan P
Oral Oncol; 2016 Nov; 62():20-27. PubMed ID: 27865368
[TBL] [Abstract][Full Text] [Related]
10. The expression and prognostic impact of proinflammatory cytokines and their associations with carcinogens in oropharyngeal squamous cell carcinoma.
Lin CM; Lin LW; Chen YW; Ye YL
Cancer Immunol Immunother; 2020 Apr; 69(4):549-558. PubMed ID: 31970439
[TBL] [Abstract][Full Text] [Related]
11. HPV-Related Oropharyngeal Cancer in Southern Thailand: Proportion Trend and Survival Outcome.
Saiya P; Jantharapattana K; Dechaphunkul A; Jirapongsak J; Thongsuksai P
Asian Pac J Cancer Prev; 2024 Jan; 25(1):57-64. PubMed ID: 38285767
[TBL] [Abstract][Full Text] [Related]
12. The "new" head and neck cancer patient-young, nonsmoker, nondrinker, and HPV positive: evaluation.
Deschler DG; Richmon JD; Khariwala SS; Ferris RL; Wang MB
Otolaryngol Head Neck Surg; 2014 Sep; 151(3):375-80. PubMed ID: 24925311
[TBL] [Abstract][Full Text] [Related]
13. A comparison between p16-positive head and neck cancer of unknown primary (HPV-HNCUP) and oropharyngeal squamous cell carcinoma (HPV-OPSCC): are they the same disease?
Balk M; Rupp R; Sievert M; Mantsopoulos K; Allner M; Grundtner P; Mueller SK; Eckstein M; Iro H; Hecht M; Gostian AO
Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5489-5497. PubMed ID: 37505261
[TBL] [Abstract][Full Text] [Related]
14. High level of Tregs is a positive prognostic marker in patients with HPV-positive oral and oropharyngeal squamous cell carcinomas.
Lukesova E; Boucek J; Rotnaglova E; Salakova M; Koslabova E; Grega M; Eckschlager T; Rihova B; Prochazka B; Klozar J; Tachezy R
Biomed Res Int; 2014; 2014():303929. PubMed ID: 24864233
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of the HPV status site-specific factor 10 (SSF-10) variable for patients with oropharyngeal cancers in the Iowa Cancer Registry, 2010-2014.
Kahl AR; Charlton ME; Pagedar NA; Sperry SM; Matt B; Platz C; Lynch CF
Head Neck; 2018 Oct; 40(10):2199-2209. PubMed ID: 29934978
[TBL] [Abstract][Full Text] [Related]
16. Multicentric human papillomavirus-associated head and neck squamous cell carcinoma.
Caley A; Evans M; Powell N; Paleri V; Tomkinson A; Urbano TG; Jay A; Robinson M; Thavaraj S
Head Neck; 2015 Feb; 37(2):202-8. PubMed ID: 24375667
[TBL] [Abstract][Full Text] [Related]
17. Importance of tumor volume, overall treatment time and fractionation sensitivity for p16-positive and p16-negative oropharyngeal tumors.
Adrian G; Gebre-Medhin M; Nilsson P
Acta Oncol; 2023 Nov; 62(11):1375-1383. PubMed ID: 37682690
[TBL] [Abstract][Full Text] [Related]
18. p16 overexpression identifies oncogenic high-risk HPV infection in non-oropharyngeal squamous cell carcinoma of the head and neck.
Becker AS; Merkel J; Bozkurt I; Strüder DF; Maletzki C; Hühns M; Zimpfer AH
Head Neck; 2024 Apr; ():. PubMed ID: 38594829
[TBL] [Abstract][Full Text] [Related]
19. Correlation of p16 immunohistochemistry with clinical and epidemiological features in oropharyngeal squamous-cell carcinoma.
de C Ferreira C; Dufloth R; de Carvalho AC; Reis RM; Santana I; Carvalho RS; Gama RR
PLoS One; 2021; 16(6):e0253418. PubMed ID: 34138935
[TBL] [Abstract][Full Text] [Related]
20. Risk and incidence of head and neck cancers in veterans living with HIV and matched HIV-negative veterans.
Mazul AL; Hartman CM; Mowery YM; Kramer JR; White DL; Royse KE; Raychaudhury S; Sandulache VC; Ahmed ST; Zevallos JP; Richardson PA; Sikora AG; Chiao EY
Cancer; 2022 Sep; 128(18):3310-3318. PubMed ID: 35867552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
